Dr. Linda Russell was born in West Islip, NY, and raised on Long Island. She received her Bachelors of Science degree, graduating Magna Cum Laude in 1985, from Tufts University. She received her MD degree, graduating Alpha Omega Alpha in 1989, from Tufts University School of Medicine in Boston, MA. Her one-year internship and her two-year residency in internal medicine were both completed at New York Hospital (1989-92). She then went to Hospital for Special Surgery for her Fellowship in Rheumatology (1992-95). Following her fellowship she joined HSS as an attending physician, where she has continued to practice medicine.
Dr. Russell has had a long-standing interest in metabolic bone disease and osteoporosis. She is the Director of the Osteoporosis and Metabolic Bone Health Center. In addition to the evaluation and care of patients with metabolic bone disease, she has focused her attention on perioperative bone health. Currently, Dr. Russell is the Co-Primary Investigator for an American College of Rheumatology guideline for the treatment of Glucocorticoid-induced Osteoporosis.
In 2011, Dr. Russell was named the Director of Perioperative Medicine at HSS. Perioperative medicine is a field of medicine that focuses on optimizing the health of patients who plan to undergo surgery and on providing medical care for those patients following surgery. As the Director of Perioperative Medicine, Dr. Russell leads a team of nine full-time internists and tenhospitalists who deliver perioperative medical care to patients undergoing surgical procedures at HSS. She also coordinates with a group of seven rheumatologists who provide additional perioperative consultation. These perioperative physicians are well acquainted with their patients’ needs before, during and after surgery, thus providing the exceptional care that HSS is known for. She also is working with a team of physicians to create a manuscript for the Society for Perioperative Assessment and Quality Improvement (SPAQI) that outlines the perioperative management of patients with Rheumatologic and HIV diseases.
Dr. Russell was recognized in 2020 by the United Hospital Fund during their Tribute to Excellence in Health Care Awards Ceremony for her passionate advocacy to promote osteoporosis and metabolic bone health as well as leading efforts to develop preoperative weight loss, diabetes management, and smoking cessation programs at HSS. Dr. Russell received “The Wholeness of Life Award” from the Healthcare Chaplaincy in 2005. She holds the Anne and Joel Ehrenkranz Chair in Perioperative Medicine.
Integrative Rheumatology and Orthopedics Center (IROC)
Osteoporosis and Metabolic Bone Health
Osteoporosis
Rheumatoid Arthritis (RA)
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Attending Physician, Hospital for Special Surgery
Associate Professor of Medicine, Weill Cornell Medical College
Vice Chair of Clinical Affairs, Department of Medicine
Director of Perioperative Services, Hospital for Special Surgery
Anne and Joel Ehrenkranz Chair in Perioperative Services
Rheumatology
Internal Medicine
Castle Connolly Top Doctor - 10 Years
Castle Connolly Top Doctors in New York Metro Area, 2014-2022
Castle Connolly Regional Top Doctor, 2013-2020
New York Magazine Top Doctors, 2013-2022
United Hospital Fund Tribute to Excellence in Health Care: Quality Improvement Champion, 2020
HSS Wholeness of Life Honoree, 2005
MD, Tufts University School of Medicine, Boston, Massachusetts
The New York Hospital - Cornell Medical Center, Internal Medicine, Non-US, US
Hospital for Special Surgery, Rheumatology, New York
English
Kahlenberg CA, Gibbons JA, Mehta B, Antao VC, Lai EY, Do HT, Russell LA, Sculco PK, Figgie MP, Goodman SM. Satisfaction with the Process versus Outcome of Care in Total Hip and Knee Arthroplasty. J Arthroplasty. 2021 Nov 10:S0883-5403(21)00845-7. doi: 10.1016/j.arth.2021.11.010.
Mehta B, Brantner C, Williams N, Szymonifka J, Navarro-Millan I, Mandl LA, Bass AR, Russell LA, Parks ML, Figgie MP, Nguyen JT, Ibrahim S, Goodman SM. Primary Care Provider Density and Elective Total Joint Replacement Outcomes. Arthroplast Today. 2021 Jul 9;10:73-78. doi: 10.1016/j.artd.2021.05.010. eCollection 2021 Aug.PMID: 34527799
Bass AR, Zhang Y, Mehta B, Do HT, Russell LA, Sculco PK, Goodman SM. Periprosthetic Joint Infection Is Associated with an Increased Risk of Venous Thromboembolism Following Revision Total Knee Replacement: An Analysis of Administrative Discharge Data. J Bone Joint Surg Am. 2021 Jul 21;103(14):1312-1318. doi: 10.2106/JBJS.20.01486.PMID: 33750744
Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Millán I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8.PMID: 34101376
Russell LA Rheumatoid Arthritis, Lupus and other Systemic Autoimmune Diseases in Decision Making in Perioperative Medicine: Clinical Pearls, editor Cohn, SL, McGraw Hill, USA, 2021, 219-224
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of May 11, 2024, Dr. Russell reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.
